<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-1249</journal-id>
<journal-title><![CDATA[Archivos de Pediatría del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Pediatr. Urug.]]></abbrev-journal-title>
<issn>1688-1249</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-12492021000101202</article-id>
<article-id pub-id-type="doi">10.31134/ap.92.1.3</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Epidemiología del cáncer en niños y adolescentes en Uruguay: 2008-2012. Un estudio de registro poblacional]]></article-title>
<article-title xml:lang="en"><![CDATA[Epidemiology of cancer in children and adolescents in Uruguay: 2008-2012. A population-based registry study]]></article-title>
<article-title xml:lang="pt"><![CDATA[Epidemiologia do câncer em crianças e adolescentes do Uruguai: 2008-2012. Um estudo de registro de base populacional]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Dufort y Álvarez]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,CHPR Servicio Hematología y Oncología Pediátrica ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2021</year>
</pub-date>
<volume>92</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-12492021000101202&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-12492021000101202&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-12492021000101202&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Objetivo:  describir la incidencia y supervivencia en niños y adolescentes con cáncer en Uruguay y analizar su evolución mediante la comparación de los períodos 1992-1994 y 2008-2012.  Material y método:  estudio observacional y descriptivo. Se incluyeron todos los pacientes entre 0 y 14 años diagnosticados de cáncer en todo el territorio uruguayo en el período 2008-2012. Fuente de datos: Registros del Servicio de Hematología y Oncología Pediátrica del Centro Hospitalario Pereira Rossell. Los diagnósticos fueron agrupados de acuerdo con la International Classification of Childhood Cancer, Third Edition. La información del tamaño de la población y de su distribución según la edad fue obtenida de registros de censos nacionales y de organismos internacionales. Se determinó incidencia y supervivencia. Se estableció el seguimiento de los sobrevivientes por un mínimo de seis años para asegurar una estimación precisa de la sobrevida.  Resultados:  se incluyeron 504 pacientes entre 0 y 14 años. La tasa de incidencia para todos los cánceres fue de 134,6 casos por millón por año, 147,6 y 120,7 para varones y niñas, respectivamente. La mayor incidencia fue observada para leucemias (grupo I) (40,6), tumores del sistema nervioso central (grupo III) (28,0) y linfomas (grupo II) (17,6). La tasa de sobrevida a cinco años mejoró significativamente para todos los cánceres de 54,7% (1992-1994) a 70,6% (2008-2012) (varones 49,2% a 69,6%; niñas 58,9% a 72,3%).  Conclusiones:  este estudio aporta información confiable de la incidencia y sobrevida del cáncer en Uruguay en pacientes menores de 15 años. Los resultados hallados demuestran cambios en la distribución de la población de Uruguay, una tasa de incidencia de cáncer estable en el grupo etario analizado y un progreso significativo en la supervivencia comparado con el estudio realizado hace 20 años, pero confirman que Uruguay tiene desafíos por delante para alcanzar tasas de cura del cáncer similares a los países de Europa Occidental y América del Norte.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary:  Objectives: describe the incidence and survival of children and adolescents with cancer in Uruguay and analyze their evolution by comparing the periods 1992-1994 and 2008-2012.  Materials and methods: descriptive and observational study. We included all patients between 0 and 14 years of age diagnosed with cancer in Uruguay during 2008-2012. Data source: Pereira Rossell Children&#8217;s Hospital Records of the Pediatric Hematology and Oncology Department. The diagnoses were grouped according to the Third Edition of the Childhood Cancer&#8217;s International Classification. Data regarding population size and distribution by age was obtained from national census records and from international organizations. We determined incidence and survival. Follow-up of survivors was established for a minimum of 6 years to ensure an accurate estimate of survival.  Results: we included five hundred and four (504) patients between 0 and 14 years of age. The incidence rate for all cancers was 134.6 cases per million per year, 147.6 and 120.7 for boys and girls, respectively. The highest incidence was leukemia (group I) (40.6), tumors of the central nervous system (group III) (28.0) and lymphomas (group II) (17.6). The 5-year survival rate improved significantly for all cancers from 54.7% (1992-1994) to 70.6% (2008-2012) (males 49.2% to 69.6%; girls 58.9% to 72.3%).  Conclusions: this study provides reliable information on the incidence and survival of cancer in Uruguay in patients under 15 years of age. The results found demonstrate changes in the distribution of the population of Uruguay, a stable cancer incidence rate in the age group analyzed and significant progress in survival compared to the study carried out 20 years ago, but confirm that Uruguay has challenges ahead in order to achieve cancer cure rates similar to those of Western European and North American countries.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Objetivos: descrever a incidência e sobrevida em crianças e adolescentes com câncer no Uruguai e analisar sua evolução comparando os períodos 1992-1994 e 2008-2012.  Materiais e métodos: estudo observacional e descritivo. Incluíram-se todos os pacientes de 0 a 14 anos de idade com diagnóstico de câncer em Uruguai no período 2008-2012. Fonte de dados: Prontuários do Serviço de Hematologia e Oncologia Pediátrica do Centro Hospitalar Pereira Rossell. Os diagnósticos foram agrupados de acordo com a Classificação Internacional de Câncer Infantil, Terceira Edição. As informações sobre o tamanho da população e sua distribuição por faixa etária foram obtidas nos registros censitários nacionais e em organismos internacionais. Determinaram-se a incidência e sobrevivência. Os sobreviventes foram acompanhados por um período mínimo de 6 anos para garantir uma estimativa precisa de sobrevida.  Resultados: incluíram-se 504 pacientes entre 0 e 14 anos de idade. A taxa de incidência para todos os cânceres foi de 134,6 casos por milhão por ano, 147,6 e 120,7 para meninos e meninas, respectivamente. A maior incidência observou-se para leucemias (grupo I) (40,6), tumores do sistema nervoso central (grupo III) (28,0) e linfomas (grupo II) (17,6). A taxa de sobrevida em 5 anos melhorou significativamente para todos os cânceres de 54,7% (1992-1994) para 70,6% (2008-2012) (homens 49,2% a 69,6%; meninas 58,9% a 72,3%).  Conclusões: este estudo fornece informação confiável sobre a incidência e sobrevida do câncer no Uruguai em pacientes com menos de 15 anos de idade. Os resultados encontrados mostram mudanças na distribuição da população uruguaia, taxa de incidência de câncer estável na faixa etária analisada e avanço significativo na sobrevida em relação ao estudo realizado há 20 anos, mas confirmam que o Uruguai tem desafios pela frente para atingir taxas de cura do câncer semelhantes aos países da Europa Ocidental e da América do Norte.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Neoplasias-epidemiología]]></kwd>
<kwd lng="es"><![CDATA[Niño]]></kwd>
<kwd lng="es"><![CDATA[Adolescente]]></kwd>
<kwd lng="es"><![CDATA[Uruguay]]></kwd>
<kwd lng="en"><![CDATA[Neoplasms-epidemiology]]></kwd>
<kwd lng="en"><![CDATA[Child]]></kwd>
<kwd lng="en"><![CDATA[Adolescent]]></kwd>
<kwd lng="en"><![CDATA[Uruguay]]></kwd>
<kwd lng="pt"><![CDATA[Neoplasias-epidemiologia]]></kwd>
<kwd lng="pt"><![CDATA[Criança]]></kwd>
<kwd lng="pt"><![CDATA[Adolescente]]></kwd>
<kwd lng="pt"><![CDATA[Uruguai]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Fluchel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dabezies]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pieri]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Brockhorst]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Barr]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Childhood cancer in Uruguay: 1992-1994: incidence and mortality]]></article-title>
<source><![CDATA[Med Pediatr Oncol]]></source>
<year>2001</year>
<volume>37</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>400-4</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Howlader]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Noone]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Krapcho]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Brest]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[SEER Cancer Statistics Review, 1975-2017.]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Bethesda, MD ]]></publisher-loc>
<publisher-name><![CDATA[National Cancer Institute]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>Instituto Nacional de Estadística</collab>
<source><![CDATA[Uruguay en cifras]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[INE]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steliarova]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Stiller]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lacour]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Kaatsch]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International Classification of Childhood Cancer, third edition]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2005</year>
<volume>103</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1457-67</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<collab>Banco Mundial</collab>
<source><![CDATA[Población entre 0 y 14 años de edad (% del total)]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>International Agency for Research on Cancer</collab>
<source><![CDATA[International Incidence of Childhood Cancer 3 results]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Lyon FR ]]></publisher-loc>
<publisher-name><![CDATA[IARC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>International Agency for Research on Cancer</collab>
<source><![CDATA[Cancer Incidence in Five Continents, Vol. XI]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Lyon FR ]]></publisher-loc>
<publisher-name><![CDATA[IARC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silveira]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Garau]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Musetti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Childhood cancer in Uruguay at the beginning of the XXIst century]]></source>
<year></year>
<volume>12</volume>
<numero>2</numero>
<conf-name><![CDATA[ 35thAnnual Meeting of the International Association of Cancer Registries]]></conf-name>
<conf-date>22-24 October 2013</conf-date>
<conf-loc>Buenos Aires, Argentina </conf-loc>
<issue>2</issue>
<page-range>309</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Linabery]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ross]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in childhood cancer incidence in the U S. (1992-2004)]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>2008</year>
<volume>112</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>416-32</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baade]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Youlden]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Valery]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hassall]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in incidence of childhood cancer in Australia, 1983-2006]]></article-title>
<source><![CDATA[Br J Cancer]]></source>
<year>2010</year>
<volume>102</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>620-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaatsch]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of childhood cancer]]></article-title>
<source><![CDATA[Cancer Treat Rev]]></source>
<year>2010</year>
<volume>36</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>277-85</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Steliarova]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Colombet]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ries]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Dolya]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bray]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International incidence of childhood cancer, 2001-10 a population-based registry study]]></article-title>
<source><![CDATA[Lancet Oncol]]></source>
<year>2017</year>
<volume>18</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>719-31</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Siegel]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tai]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Buchanan]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ajani]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2014</year>
<volume>134</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>e945-55</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lacour]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Goujon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Guissou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Guyot]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Desmée]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Désandes]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Childhood cancer survival in France, 2000-2008]]></article-title>
<source><![CDATA[Eur J Cancer Prev]]></source>
<year>2014</year>
<volume>23</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>449-57</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nakata]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Ito]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Magadi]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Bonaventure]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Stiller]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Katanoda]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Childhood cancer incidence and survival in Japan and England A population-based study (1993-2010)]]></article-title>
<source><![CDATA[Cancer Sci]]></source>
<year>2018</year>
<volume>109</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>422-34</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karim]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hackl]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mann]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Urban]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Woehrer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Slavc]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994-2011]]></article-title>
<source><![CDATA[Cancer Epidemiol]]></source>
<year>2016</year>
<volume>42</volume>
<page-range>72-81</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Moon]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Yoon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Oh]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence and survival of childhood cancer in Korea]]></article-title>
<source><![CDATA[Cancer Res Treat]]></source>
<year>2016</year>
<volume>48</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>869-82</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gatta]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Botta]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Aareleid]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bielska]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Clavel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Childhood cancer survival in Europe 1999-2007: results of EUROCARE-a population-based study]]></article-title>
<source><![CDATA[Lancet Oncol]]></source>
<year>2014</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>35-47</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ladenstein]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Pötschger]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Valteau]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Luksch]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Castel]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ash]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Investigation of the role of Dinutuximab beta-based immunotherapy in the SIOPEN high-risk neuroblastoma 1 Trial (HR-NBL1)]]></article-title>
<source><![CDATA[Cancers (Basel)]]></source>
<year>2020</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>309</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hunger]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Raetz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How I treat relapsed acute lymphoblastic leukemia in the pediatric population]]></article-title>
<source><![CDATA[Blood]]></source>
<year>2020</year>
<volume>136</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>1803-12</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
